377 580

Cited 1 times in

Infliximab, Is It Really a New Horizon for the Treatment of Kawasaki Disease?

DC Field Value Language
dc.contributor.author은영민-
dc.date.accessioned2019-04-03T07:50:47Z-
dc.date.available2019-04-03T07:50:47Z-
dc.date.issued2019-
dc.identifier.issn1738-5520-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/167766-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish, Korean-
dc.publisherKorean Society of Circulation-
dc.relation.isPartOfKOREAN CIRCULATION JOURNAL-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleInfliximab, Is It Really a New Horizon for the Treatment of Kawasaki Disease?-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Pediatrics (소아청소년과학교실)-
dc.contributor.googleauthorLucy Youngmin Eun-
dc.identifier.doi10.4070/kcj.2018.0460-
dc.contributor.localIdA02634-
dc.relation.journalcodeJ01952-
dc.identifier.eissn1738-5555-
dc.identifier.pmid30693682-
dc.contributor.alternativeNameEun, Lucy Youngmin-
dc.contributor.affiliatedAuthor은영민-
dc.citation.volume49-
dc.citation.number2-
dc.citation.startPage192-
dc.citation.endPage193-
dc.identifier.bibliographicCitationKOREAN CIRCULATION JOURNAL, Vol.49(2) : 192-193, 2019-
dc.identifier.rimsid58363-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.